Related references
Note: Only part of the references are listed.A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model
Anwar M. Hashem et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Protective Antibodies Against Influenza Proteins
Herbey O. Padilla-Quirarte et al.
FRONTIERS IN IMMUNOLOGY (2019)
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
Chean Yeah Yong et al.
FRONTIERS IN MICROBIOLOGY (2019)
Development and validation of different indirect ELISAs for MERS-CoV serological testing
Anwar M. Hashem et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2019)
A study of the probable transmission routes of MERS-CoV during the first hospital outbreak in the Republic of Korea
S. Xiao et al.
INDOOR AIR (2018)
MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity
Daniel K. W. Chu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The prevalence of Middle East respiratory Syndrome coronavirus (MERS-CoV) infection in livestock and temporal relation to locations and seasons
Samy Kasem et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2018)
Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
L. Coughlan et al.
EBIOMEDICINE (2018)
Prospects for a MERS-CoV spike vaccine
Yusen Zhou et al.
EXPERT REVIEW OF VACCINES (2018)
Reported Direct and Indirect Contact with Dromedary Camels among Laboratory-Confirmed MERS-CoV Cases
Romy Conzade et al.
VIRUSES-BASEL (2018)
High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia
Abeer N. Alshukairi et al.
MBIO (2018)
Vaccines against Middle East respiratory syndrome coronavirus for humans and camels
Naif Khalaf Alharbi
REVIEWS IN MEDICAL VIROLOGY (2017)
Risk factors for MERS coronavirus infection in dromedary camels in Burkina Faso, Ethiopia, and Morocco, 2015
E. Miguel et al.
EUROSURVEILLANCE (2017)
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
Naif Khalaf Alharbi et al.
VACCINE (2017)
Diversity of Middle East respiratory syndrome coronaviruses in 109 dromedary camels based on full-genome sequencing, Abu Dhabi, United Arab Emirates
Mohammed Farouk Yusof et al.
EMERGING MICROBES & INFECTIONS (2017)
Longitudinal study of Middle East Respiratory Syndrome coronavirus infection in dromedary camel herds in Saudi Arabia, 2014-2015
Maged Gomaa Hemida et al.
EMERGING MICROBES & INFECTIONS (2017)
Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt
Mohamed A. Ali et al.
EMERGING MICROBES & INFECTIONS (2017)
Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
Vincent J. Munster et al.
NPJ VACCINES (2017)
Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia
Samy Kasem et al.
Journal of Infection and Public Health (2017)
Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction
V M Corman et al.
Eurosurveillance (2017)
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
Bart L. Haagmans et al.
SCIENCE (2016)
Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
George M. Warimwe et al.
SCIENTIFIC REPORTS (2016)
Time Course of MERS-CoV Infection and Immunity in Dromedary Camels
Benjamin Meyer et al.
EMERGING INFECTIOUS DISEASES (2016)
Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein
Asisa Volz et al.
JOURNAL OF VIROLOGY (2015)
Serological Evidence of MERS-CoV Antibodies in Dromedary Camels (Camelus dromedaries) in Laikipia County, Kenya
Sharon L. Deem et al.
PLOS ONE (2015)
An optimised method for the production of MERS-CoV spike expressing viral pseudotypes
K. Grehan et al.
METHODSX (2015)
Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity
M. G. Hemida et al.
EUROSURVEILLANCE (2014)
Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
Richard D. Antrobus et al.
MOLECULAR THERAPY (2014)
Evidence for Camel-to-Human Transmission of MERS Coronavirus
Esam I. Azhar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
MERS Coronavirus Neutralizing Antibodies in Camels, Eastern Africa, 1983-1997
Marcel A. Mueller et al.
EMERGING INFECTIOUS DISEASES (2014)
Geographic Distribution of MERS Coronavirus among Dromedary Camels, Africa
Chantal B. E. M. Reusken et al.
EMERGING INFECTIOUS DISEASES (2014)
Replication and Shedding of MERS-CoV in Upper Respiratory Tract of Inoculated Dromedary Camels
Danielle R. Adney et al.
EMERGING INFECTIOUS DISEASES (2014)
Antibodies against MERS Coronavirus in Dromedary Camels, Kenya, 1992-2013
Victor M. Corman et al.
EMERGING INFECTIOUS DISEASES (2014)
MERS Coronavirus in Dromedary Camel Herd, Saudi Arabia
Maged G. Hemida et al.
EMERGING INFECTIOUS DISEASES (2014)
Antibodies against MERS Coronavirus in Dromedaries, United Arab Emirates, 2003 and 2013
Benjamin Meyer et al.
EMERGING INFECTIOUS DISEASES (2014)
Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013
R Perera et al.
Eurosurveillance (2013)
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
Chantal B. E. M. Reusken et al.
LANCET INFECTIOUS DISEASES (2013)
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Guangwen Lu et al.
NATURE (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
Matthew D. J. Dicks et al.
PLOS ONE (2012)
Experimental infection of bats with Geomyces destructans causes white-nose syndrome
Jeffrey M. Lorch et al.
NATURE (2011)
Effective induction of high-titer antibodies by viral vector vaccines
Simon J. Draper et al.
NATURE MEDICINE (2008)
Share Paper
